Cargando…

Influence of Healthcare-Associated Factors on the Efficacy of Hepatitis C Therapy

Hepatitis C infection is a complex entity associated with sizable morbidity and mortality, with great social and economic consequences that put a heavy potential burden on healthcare systems allover the world. Despite the great improvement of hepatitis C virus (HCV) therapy and its high clinical eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daw, Mohamed A., Dau, Aghynya A., Agnan, Mohamed M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543794/ https://www.ncbi.nlm.nih.gov/pubmed/23346018 http://dx.doi.org/10.1100/2012/580216

Ejemplares similares

Hepatitis C Virus in North Africa: An Emerging Threat
por: Daw, Mohamed A., et al.
Publicado: (2016)

Geographic integration of hepatitis C virus: A global threat
por: Daw, Mohamed A, et al.
Publicado: (2016)

The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016
por: Daw, Mohamed A., et al.
Publicado: (2018)

Hepatitis C Virus in Arab World: A State of Concern
por: Daw, Mohamed A., et al.
Publicado: (2012)

Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients
por: Elasifer, Hana A, et al.
Publicado: (2010)

Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission
por: Daw, Mohamed A, et al.
Publicado: (2015)

Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey
por: Daw, Mohamed A, et al.
Publicado: (2014)

The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis
por: Daw, Mohamed A., et al.
Publicado: (2018)

Seroprevalence of HBV, HCV & HIV Co-Infection and Risk Factors Analysis in Tripoli-Libya
por: Daw, Mohamed A., et al.
Publicado: (2014)

Libyan healthcare system during the armed conflict: Challenges and restoration
por: Daw, Mohamed A.
Publicado: (2017)

Molecular and epidemiological characterization of HIV-1 subtypes among Libyan patients
por: Daw, Mohamed A., et al.
Publicado: (2017)

The epidemiological characterization and geographic distribution of hepatitis D virus infection in Libya
por: Daw, Mohamed Ali, et al.
Publicado: (2020)

Trends and patterns of deaths, injuries and intentional disabilities within the Libyan armed conflict: 2012-2017
por: Daw, Mohamed A., et al.
Publicado: (2019)

Host factors determining the efficacy of hepatitis C treatment
por: Chuang, Wan-Long, et al.
Publicado: (2012)

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
por: El Kassas, Mohamed, et al.
Publicado: (2019)

Factors influencing willingness to pay for healthcare
por: Noor Aizuddin, Azimatun, et al.
Publicado: (2012)

Epidemiological manifestations and impact of healthcare-associated infections in Libyan national hospitals
por: Daw, Mohamed Ali, et al.
Publicado: (2023)

Factors that influence adult neurogenesis as potential therapy
por: Shohayeb, Belal, et al.
Publicado: (2018)

Retinopathy associated with interferon therapy in patients with hepatitis C virus
por: Abd El-Badie Mohamed, Mahmoud, et al.
Publicado: (2012)

Vasculitic syndromes in hepatitis C virus: A review
por: Ragab, Gaafar, et al.
Publicado: (2017)

Hepatitis C Viral Infection in Children: Updated Review
por: El-Guindi, Mohamed A.
Publicado: (2016)

Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy
por: Emara, Mohamed H, et al.
Publicado: (2010)

Emerging Therapies for Hepatitis C
por: Kim, Do Young, et al.
Publicado: (2014)

Emerging therapies for the treatment of hepatitis C
por: Lange, Christian M, et al.
Publicado: (2014)

Behavioral and Healthcare-Associated Risk Factors for Chronic Hepatitis C Virus Infection in Korea
por: Kim, Jong Yeop, et al.
Publicado: (2012)

Fibrosis regression following hepatitis C antiviral therapy
por: Elsharkawy, Aisha, et al.
Publicado: (2022)

Reproducing kernel hilbert spaces in probability and statistics
por: Berlinet, Alain, et al.
Publicado: (2004)

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
por: Mravčík, Viktor, et al.
Publicado: (2013)

Hepatitis C genotype and associated risks factors of patients at University Kebangsaan Malaysia Medical Centre
por: Mohamed, N.A., et al.
Publicado: (2013)

Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
por: Mostafa, Waleed Seif Eldin Mohamed, et al.
Publicado: (2020)

Assessment of Hepatitis B Vaccination Status and Associated Factors among Healthcare Workers in Bosaso, Puntland, Somalia 2020
por: Hussein, Nur Ahmed, et al.
Publicado: (2022)

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy
por: Refaat, Bassem, et al.
Publicado: (2015)

Efficacy and Safety of Daclatasvir in Hepatitis C: An Overview
por: Gamal, Nesrine, et al.
Publicado: (2016)

Dual versus triple therapy in treatment of hepatitis C virus (HCV)
por: Bishai, Nevine, et al.
Publicado: (2022)

Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies
por: Wang, Chun-Hsiang, et al.
Publicado: (2010)

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
por: Afdhal, N H, et al.
Publicado: (2013)

Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma
por: Ismail, Mohamed Saleh, et al.
Publicado: (2020)

Hepatitis C treatment: where are we now?
por: Burstow, Nicholas J, et al.
Publicado: (2017)

Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
por: Kondo, C, et al.
Publicado: (2016)

Frequent Transient Hepatitis C viremia without Seroconversion among Healthcare Workers in Cairo, Egypt
por: Munier, Aline, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8g1in4fclqbgl1us0d61n8fgb4